• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肝切除术后早期复发的危险因素

The risk factors of early recurrence after hepatectomy in hepatocellular carcinoma.

作者信息

Kwon Soon-Keun, Yun Sung-Su, Kim Hong-Jin, Lee Dong-Shik

机构信息

Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea.

出版信息

Ann Surg Treat Res. 2014 Jun;86(6):283-8. doi: 10.4174/astr.2014.86.6.283. Epub 2014 May 23.

DOI:10.4174/astr.2014.86.6.283
PMID:24949318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4062445/
Abstract

PURPOSE

Early recurrence after hepatectomy is a well-known poor prognostic factor in patients with hepatocellular carcinoma. This study was undertaken to identify the risk factors of early recurrence in patients with hepatocellular carcinoma after hepatectomy.

METHODS

One hundred and sixty-seven patients that underwent hepatectomy for hepatocellular carcinoma from January 2005 to December 2010 were enrolled. The numbers of patients with or without early recurrence group were 40 and 127, respectively. Clinico-pathologic factors were retrospectively analyzed.

RESULTS

Potential risk factors were classified as host, tumor, or surgical factors. Of the host factors examined, lobular hepatitis activity was found to be a significant risk factor of early recurrence, and of the tumor factors, infiltrative type of gross appearance, level of preoperative AFP and worst Edmondson-Steiner grade were significant.

CONCLUSION

The present study shows that an infiltrative gross appearance, a high preoperative AFP level, high lobular hepatitis activity, and a poor Edmondson-Steiner grade are independent risk factors of early recurrence. Accordingly, patients with these risk factors should be followed closely after hepatectomy.

摘要

目的

肝切除术后早期复发是肝细胞癌患者公认的不良预后因素。本研究旨在确定肝细胞癌患者肝切除术后早期复发的危险因素。

方法

纳入2005年1月至2010年12月期间因肝细胞癌接受肝切除术的167例患者。早期复发组和无早期复发组的患者人数分别为40例和127例。对临床病理因素进行回顾性分析。

结果

潜在危险因素分为宿主、肿瘤或手术因素。在检查的宿主因素中,小叶性肝炎活动度被发现是早期复发的一个重要危险因素,在肿瘤因素中,大体外观浸润型、术前甲胎蛋白水平和最差的埃德蒙森-斯坦纳分级是显著的。

结论

本研究表明,大体外观浸润型、术前甲胎蛋白水平高、小叶性肝炎活动度高和埃德蒙森-斯坦纳分级差是早期复发的独立危险因素。因此,有这些危险因素的患者在肝切除术后应密切随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/4062445/18e5ab3d864b/astr-86-283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/4062445/18e5ab3d864b/astr-86-283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/4062445/18e5ab3d864b/astr-86-283-g001.jpg

相似文献

1
The risk factors of early recurrence after hepatectomy in hepatocellular carcinoma.肝细胞癌肝切除术后早期复发的危险因素
Ann Surg Treat Res. 2014 Jun;86(6):283-8. doi: 10.4174/astr.2014.86.6.283. Epub 2014 May 23.
2
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.埃德蒙森-施泰纳分级:无微血管侵犯的肝细胞癌复发和生存的关键预测指标。
Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.
3
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
4
Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion.微血管侵犯的可切除肝细胞癌患者复发和生存不良的危险因素。
Adv Clin Exp Med. 2020 Jul;29(7):887-892. doi: 10.17219/acem/76750.
5
The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.术前血清乙肝e抗原阳性并不影响乙肝病毒相关肝细胞癌根治性切除术后的总生存期。
J Gastroenterol Hepatol. 2009 Mar;24(3):391-8. doi: 10.1111/j.1440-1746.2008.05637.x. Epub 2009 Nov 20.
6
Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma.肝细胞癌根治性肝切除术后早期复发的危险因素
Tumour Biol. 2017 Oct;39(10):1010428317720863. doi: 10.1177/1010428317720863.
7
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.肝癌患者肝切除术后 1 年内因疾病复发或进展导致早期死亡的危险因素分析。
World J Surg Oncol. 2012 Jun 14;10:107. doi: 10.1186/1477-7819-10-107.
8
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.肝癌肝切除术后血清甲胎蛋白和甲胎蛋白-L3 的变化:预后意义。
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23. doi: 10.1016/s1499-3872(12)60234-3.
9
Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy.肝移植后肝细胞癌的预后:与肝部分切除术的比较分析
J Pathol Transl Med. 2017 Jan;51(1):79-86. doi: 10.4132/jptm.2016.10.13. Epub 2016 Dec 25.
10
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.应用术前扁豆凝集素结合型甲胎蛋白预测肝癌根治性切除术后复发。
Hepatol Res. 2012 Sep;42(9):887-94. doi: 10.1111/j.1872-034X.2012.01004.x. Epub 2012 Apr 23.

引用本文的文献

1
Alpha-fetoprotein-to-PIVKA-II ratio as a potential biomarker for hepatocellular carcinoma differentiation, imaging characteristics, and patient survival.甲胎蛋白与异常凝血酶原-II比值作为肝细胞癌分化、影像学特征及患者生存的潜在生物标志物。
Transl Cancer Res. 2024 Nov 30;13(11):5929-5942. doi: 10.21037/tcr-24-958. Epub 2024 Nov 14.
2
Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.基于钆塞酸二钠增强 MRI 的深度学习列线图预测肝癌切除术后早期复发。
Eur Radiol. 2023 Jul;33(7):4949-4961. doi: 10.1007/s00330-023-09419-0. Epub 2023 Feb 14.
3

本文引用的文献

1
Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.同步多结节肝细胞癌患者多中心发生及肝内转移的临床病理特征与预后
Asian Pac J Cancer Prev. 2013;14(1):217-23. doi: 10.7314/apjcp.2013.14.1.217.
2
Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.弥漫浸润性肝细胞癌:临床表现、治疗和结局评估。
Ann Surg Oncol. 2012 Sep;19(9):2897-907. doi: 10.1245/s10434-012-2336-0. Epub 2012 Apr 3.
3
Infiltrating hepatocellular carcinoma: seeing the tree through the forest.
Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity.
解剖性切除对术前正电子发射断层扫描阳性或阴性的原发性孤立性肝细胞癌肝切除术后长期预后的临床影响
Ann Transl Med. 2020 Nov;8(21):1377. doi: 10.21037/atm-20-1583.
4
Development and Validation of a Clinicopathological-Based Nomogram to Predict the Survival Outcome of Patients with Recurrent Hepatocellular Carcinoma After Hepatectomy Who Underwent Microwave Ablation.基于临床病理特征的列线图的开发与验证,用于预测肝切除术后接受微波消融的复发性肝细胞癌患者的生存结局
Cancer Manag Res. 2020 Aug 21;12:7589-7600. doi: 10.2147/CMAR.S266052. eCollection 2020.
5
Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.钆塞酸增强磁共振成像纹理分析预测肝细胞癌Ki-67状态的前瞻性研究
Chin J Cancer Res. 2019 Oct;31(5):806-817. doi: 10.21147/j.issn.1000-9604.2019.05.10.
6
Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.用于改进参数化和动态寿命分析的癌症生存数据表示
Healthcare (Basel). 2019 Oct 28;7(4):123. doi: 10.3390/healthcare7040123.
7
Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.经肝动脉化疗栓塞术治疗后的肝细胞癌患者的放射性栓塞治疗。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1721-1730. doi: 10.1007/s00259-018-3968-5. Epub 2018 Mar 7.
8
Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.钆塞酸二钠增强磁共振成像联合T1映射预测肝细胞癌的分化程度。
BMC Cancer. 2016 Aug 12;16:625. doi: 10.1186/s12885-016-2607-4.
9
A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.单结节肝细胞癌切除术后肝内复发、早期复发和多次复发危险因素的比较。
Korean J Hepatobiliary Pancreat Surg. 2015 Aug;19(3):89-97. doi: 10.14701/kjhbps.2015.19.3.89. Epub 2015 Aug 28.
浸润性肝细胞癌:见林而非树。
J Gastrointest Surg. 2011 Nov;15(11):2089-97. doi: 10.1007/s11605-011-1614-7. Epub 2011 Jul 2.
4
Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B.慢性乙型肝炎患者发生肝细胞癌的组织学特征。
J Clin Pathol. 2011 Jul;64(7):599-604. doi: 10.1136/jclinpath-2011-200036. Epub 2011 May 14.
5
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.根治性切除术后小肝细胞癌早期复发的危险因素。
Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):33-7.
6
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.乙肝相关性肝细胞癌早期及晚期复发的危险因素。
J Hepatol. 2009 Nov;51(5):890-7. doi: 10.1016/j.jhep.2009.07.009. Epub 2009 Jul 23.
7
Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification.根治性切除巨大 (>或=10 cm) 肝细胞癌的疗效及大体肿瘤分类的预后意义。
Am J Surg. 2009 Nov;198(5):693-701. doi: 10.1016/j.amjsurg.2008.09.019. Epub 2009 Mar 6.
8
Long-term outcome of chronic hepatitis B based on histological grade and stage.基于组织学分级和分期的慢性乙型肝炎长期预后
J Gastroenterol Hepatol. 2007 Mar;22(3):383-8. doi: 10.1111/j.1440-1746.2007.04857.x.
9
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.肝细胞癌切除术后早期复发相关因素及预后
J Am Coll Surg. 2006 Feb;202(2):275-83. doi: 10.1016/j.jamcollsurg.2005.10.005. Epub 2005 Dec 19.
10
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.